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Mitochondrial dysfunction impairs 
osteogenesis, increases osteoclast 
activity, and accelerates age 
related bone loss
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Doug M. turnbull1,2,5* & Laura c. Greaves 1,3,5*
the pathogenesis of declining bone mineral density, a universal feature of ageing, is not fully 
understood. Somatic mitochondrial DnA (mtDnA) mutations accumulate with age in human tissues 
and mounting evidence suggests that they may be integral to the ageing process. to explore the 
potential effects of mtDNA mutations on bone biology, we compared bone microarchitecture 
and turnover in an ageing series of wild type mice with that of the PolgAmut/mut mitochondrial DnA 
‘mutator’ mouse. in vivo analyses showed an age-related loss of bone in both groups of mice; 
however, it was significantly accelerated in the PolgAmut/mut mice. this accelerated rate of bone 
loss is associated with significantly reduced bone formation rate, reduced osteoblast population 
densities, increased osteoclast population densities, and mitochondrial respiratory chain deficiency 
in osteoblasts and osteoclasts in PolgAmut/mut mice compared with wild-type mice. in vitro assays 
demonstrated severely impaired mineralised matrix formation and increased osteoclast resorption 
by PolgAmut/mut cells. finally, application of an exercise intervention to a subset of PolgAmut/mut mice 
showed no effect on bone mass or mineralised matrix formation in vitro. Our data demonstrate 
that mitochondrial dysfunction, a universal feature of human ageing, impairs osteogenesis and is 
associated with accelerated bone loss.
Normal bone homeostasis requires maintenance of a delicate balance between the continuous processes of bone 
resorption by osteoclasts and new bone formation by  osteoblasts1,2. Following attainment of peak bone mass in 
early adulthood, a decline in bone mineral density (BMD) ensues and continues unabated for the remainder 
of life in both humans and  mice3,4. Progressive deterioration in bone microarchitecture with declining miner-
alisation levels and increasing porosity occurs, frequently culminating in  osteoporosis5–7. The process affects 
males and females universally, with a transiently accelerated rate of loss observed in the latter secondary to 
menopausal oestrogen loss in  humans3,8. Diminishing bone strength is inherent to declining BMD levels, the 
consequence of which is increasing risk of fragility fractures occurring with increasing  age9,10. The pathogenesis 
of bone loss is not fully understood with various theories postulated such as increasing secretion of endogenous 
 glucocorticoids11,12 and decreasing levels of sex  hormones13–16, physical activity  levels17–19 and insulin like growth 
factor  I20,21. However, intracellular changes within bone tissue that occur with age, specifically accumulating 
mitochondrial DNA (mtDNA) mutations, may play a significant role in the failure of bone homeostasis leading 
to declining BMD levels.
With age, somatic mtDNA mutations accumulate in post mitotic tissues such a brain and  muscle22–25, and 
mitotic tissue such as  gut26,27. Mounting evidence in recent years, particularly that provided by animal models, 
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has suggested that these may be intrinsic to the ageing  process28–30. One of the most important functions of 
mitochondria in any cell is the production of energy in the form of adenosine triphosphate (ATP) via the pro-
cess of oxidative  phosphorylation31, although some ATP production can occur via much less efficient pathways 
such as glycolysis. For normal cellular function to occur, a minimum energy requirement must  exist32. Cellular 
dysfunction has been shown to occur once genomes containing mtDNA mutations outnumber the presence of 
normal mtDNA sufficiently, depending on the type of mutations present, a phenomenon known as the threshold 
 effect33,34.
mtDNA polymerase gamma (Polg) is the only DNA polymerase found in mitochondria and is responsible for 
replication and repair of mtDNA within all cell  types35. The PolgAmut/mut mitochondrial ‘mutator’ mouse possesses 
a defective version of the only proof reading domain of mtDNA  polymerase36 which causes it to accumulate 
mitochondrial DNA point mutations at 3–5 times the rate of wild type mice resulting in a premature ageing 
phenotype, making it an excellent mouse model of  ageing37. One of the most prominent consequences of this 
prematurely ageing phenotype is osteoporosis. Further evidence for mitochondrial dysfunction as a potential 
contributor to osteoporosis is seen in mice with a mitochondrial transcription factor A (TFAM) knockout 
specific to osteoclasts, the result of which is increased resorption when grown on dentine compared to normal 
 osteoclasts38. Mice with global and osteocyte specific knockdown of superoxide dismutase (Sod2), an enzyme 
which protects against mitochondrial oxidative stress, also develop osteoporosis  prematurely39.
Previous work studying the effects of exercise on PolgAmut/mut mice, showed that regular exercise over a 
5 month period ameliorated the increased rate of mtDNA mutations, increased mtDNA copy number and 
completely abolished the accelerated ageing phenotype, at 8 months of age. However, the effects of exercise on 
accelerated bone depletion was not  evaluated40. Similarly, endurance exercise in human subjects has been shown 
to increase oxidative capacity of mitochondria within muscle, although the effects on bone mass are  unknown41,42.
The normal function of osteoblasts in producing bone entails the production of a collagen framework and its 
subsequent  mineralisation43. The susceptibility of this cell line to mtDNA mutations was previously unknown. 
We developed a quadruple immunofluorescence assay which accurately quantifies respiratory chain protein 
expression in bone cells, and demonstrated that mitochondrial COX-I and NDUFB8 protein expression in 
bone lining osteoblasts decreases with age in wild type mice (4 months vs. 11 months old), and is significantly 
reduced in PolgAmut/mut mice aged 11 months compared to age matched wild type  controls44. In order to evaluate 
the potential effects of osteoblast and osteoclast mitochondrial dysfunction on bone homeostasis, here we have 
assessed the effects of the PolgAmut/mut genotype on bone phenotype, capacity of osteogenic cell lines to form 
mineralised matrix in vitro, osteoclast respiratory protein expression and resorption capacity in vitro. The effects 
of exercise on bone phenotype and in vitro mineralisation are also presented.
Methods
Mice. Mitochondrial mutator mice (PolgAmut/mut) were generated that had a knock-in missense mutation 
(D257A) in the second endonuclease proofreading domain of the PolgA catalytic subunit of the mtDNA pol-
ymerase, using a C57BL/6 background  mouse28. Female and male mice were used, with comparisons made 
between PolgAmut/mut and wild type controls from the previous generation to ensure no transmission of mtDNA 
mutations to ‘wild-type’ mice through the maternal  line45. Animals were housed in single sex cages and cared for 
in compliance with the Animals (Scientific Procedures) Act 1984 in a purpose built facility. There was no variance 
in housing conditions, feed or water provision between PolgAmut/mut and wild type littermate controls. All animal 
experiments were approved by and conducted in compliance with the UK Home Office (PPL P3052AD70) and 
the Newcastle University Animal Welfare Ethical Review Board (AWERB 425).
Assessment of volumetric bone (BV/tV). Lumbar spines and femurs were extracted from mice aged 4, 
7 and 11 months and fixed for 72 h in 10% normal buffered formalin (NBF) after removal of soft tissues. Micro 
computed tomography (CT) scans of the lumbar spines and distal femur were then performed to determine BV/
TV. Imaging was performed using a Skyscan 1,272 micro CT scanner. A beam intensity of 50Kv and 200µA was 
used with a 0.5 ml Al filter. A resolution of 4.3 µm and specimen rotation angle of 0.3° was used for femoral 
trabecular scans and a resolution of 8.6 µm and specimen rotation angle of 0.5 was used for femoral cortical 
scans. For lumbar vertebrae assessment, the L5 vertebrae was assessed, not including cortical bone or end plates. 
A resolution of 4.5 µm and a specimen rotation angle of 0.4 was used. Volumetric bone mass was recorded as a 
measure of bone volume (BV)/tissue volume (TV). Trabecular thickness, trabecular separation and trabecular 
number were also recorded in femoral and lumbar vertebrae trabecular bone. Cortical thickness was measured 
in diaphyseal femoral cortical bone.
Bone histomorphometry. Tibiae from female mice aged 7 months were dissected, fixed in 4% formalde-
hyde for 24 h and embedded in methyl methacrylate without decalcification. 5 μm sections were taken for bone 
histomorphometry, performed as detailed  previously46. In brief, sections were stained with Von Kossa stain to 
analyse bone mineralisation, 1% Toluidine blue to analyse osteoblast number, and stained for tartrate-resistant 
acid phosphatase (TRAcP) to analyse osteoclast number and surface area. To study the dynamic properties of 
bone, mice were injected intra-peritoneally 10-days and 2-days prior to sacrifice with 30 mg/kg alizarin com-
plexone and 20 mg/kg calcein in a 2% sodium bicarbonate pH 7.4 solution, respectively. Trabecular bone histo-
morphometric measurements were taken from fluorescent images of 5 μm sections acquired using a Zeiss Axio 
Imager 2 microscope and were used to calculate the bone formation rate (BFR). All bone histomorphometry 
analyses were performed on matched sections from 3 mice per genotype and were performed on the trabecular 
bone in the proximal tibia, 100 μm below the physis.
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in vitro assessment of mineralised matrix formation by osteogenic cells. Cells from mice aged 
4, 7 and 11 months were compared. Following dissection of mouse femurs, the epiphyses were cut and the bone 
marrow from individual femurs was harvested by flushing the intramedullary canal with DMEM using a 25G 
needle. Each sample was centrifuged at 300× g and the supernatant removed, before the cell pellet was suspended 
in a T25 flask in 5mls of alpha modified minimum essential media (MEM). Alpha MEM was supplemented with 
10% FBS, 2 mM L-glutamine, penicillin (100 u/ml), streptomycin (100 µg/ml) and amphotericin (0.25 µg/ml). 
After 24 h of incubation at 37 °C non-adherent cells were removed, aided by PBS wash steps, following which 
fresh media was applied. Media was changed again on day 6 and cells were harvested for use in mineralisation 
assays on day 10. At this point, cells were washed with PBS and dissociated using TrypLE express. Cells from 
each mouse were then plated at a density of 6.5 × 104 in all wells of a 12 well plate in osteogenic media (alpha 
MEM supplemented as above with the addition of 50 µg/ml sodium ascorbate and 2 mM beta-glycerophos-
phate47. A full media change was performed every 3 days for 21 days at which point the cells were fixed briefly 
in 4% PFA. 7 of the wells were washed in 70% ethanol, air dried, stained with 2% alizarin red (which binds to 
calcium within mineralised bone) in  dH2O for 10 min, washed 3 times with 50% ethanol and air dried. The 5 
remaining wells were washed with TBS prior to ALP staining which was performed by combining 10 mg napthol 
MX (dissolved in 400 µl N,N-Dimethylformamide), with 60 mg of fast blue RR salt (Sigma F0500) in 100mls of 
tris-buffered saline (TBS), at a pH of 8.2. Cells were incubated in the dark for 30 min in this solution, following 
which, nuclei of cells within the same 5 wells were stained with Hoechst. As per previous work, we confirmed 
osteogenic differentiation in vitro by staining for ALP  activity47–53. ALP is a phospho-ester, imperative to the 
mineralisation  process54,55.
Fluorescent microscopy (405 nm) was used to image Hoechst stained cells, with 15 images taken from each 
of 5 wells at 4× magnification. Matlab automated software was used to record cell counts from these images. 26 
colour brightfield images were taken of all alizarin red and ALP stained wells at 4× magnification. Image analysis 
was performed using an RGB filter within Volocity (PerkinElmer, Coventry, UK) software to detect alizarin red 
staining and the purple of ALP staining. The average surface area of mineralisation as depicted by alizarin red 
staining was recorded for each mouse cell line, as was the surface area and number of osteogenic cells, identified 
by positive ALP staining. Final results were expressed as average surface area of mineralisation per average area 
of ALP stained cells. To calculate population density of osteogenic cells in each image, the ratio of ALP positive 
cells to total cell count per image (as identified by Hoescht nuclear staining) was also recorded for each cell line.
Effects of exercise on bone and phenotype and in vitro mineralisation. A subset of male Pol-
gAmut/mut mice were exercised from the age of 16 weeks, for 4 days per week using a treadmill. Following an initial 
10-week acclimatisation period of gradually increasing intensity, the final protocol consisted of the mice running 
at 12 cm/s for 5 min, 20 cm/s for 40 min, and finally for 12 cm/s for 5 min on each of the 4 days. Tissue was 
harvested from mice aged 11 months to study whether exercise had any effects on bone density and functional 
capacity of osteogenic cells, in comparison to non-exercised PolgAmut/mut mice aged 11 months.
in vitro assessment of osteoclast function. Osteoclasts from male PolgAmut/mut and wild type litter 
mates, aged 11 months were compared using a previously published  method56. On day 1, following dissection 
of mouse femurs, the epiphyses were cut and the bone marrow from individual femurs was harvested by flush-
ing the intramedullary canal with DMEM using a 25G needle. Each sample was centrifuged at 300× g and the 
supernatant removed, before the cell pellet was suspended in a T25 flask in 5mls of alpha modified minimum 
essential media (MEM). Alpha-MEM was supplemented with 10% FBS, 2 mM L-glutamine, penicillin (100u/
ml), streptomycin (100 µg/ml) and amphotericin (0.25 µg/ml),  10−7 M prostaglandin  E2 and 2.5 ng/ml of M-CSF. 
Cells were incubated for 24 h at 37 °C in an incubator supplemented with 5%  CO2.
On day 2, non-adherent cells from each flask were removed, aided by PBS wash steps. These were centrifuged 
at 300× g for 5 min and the supernatant removed. The cell pellet was then suspended in alpha MEM at a density 
of 5 × 106 cells/ml. Alpha-MEM was supplemented at this stage and for the remainder of the experiment with 
10% FBS, 2 mM L-glutamine, penicillin (100 u/ml), streptomycin (100 µg/ml), amphotericin (0.25 µg/ml),  10-7 M 
prostaglandin  E2, 10 ng/ml M-CSF and 3 ng/ml of mouse RANKL. Using 96-well plates, cells from each mouse 
were seeded on to four 0.5 mm dentine discs (1 × 106 cells per disc in 200 µl media. Dentine was derived from 
walrus tusk (Oxford Biosystems), and had been pre-soaked in PBS.
Following a further 24 h, on day 3, discs were transferred to 6 well plates, with 2 mls of fresh supplemented 
alpha MEM in each well. A 50% media change was carried out on day 5. On day 7, a full media change was 
performed with the media having been acidified with the addition of HCl to reduce the pH to 6.9 (at incubator 
conditions) to activate osteoclast resorption. After 24 h in acidified media, dentine discs were washed in PBS 
and fixed using 2% glutaraldehyde in Sorensen’s solution, for 5 min.
TRAP staining was performed to detect osteoclasts. Osteoclasts were defined as TRAP positive, multi-nucle-
ated cells. TRAP staining solution, pH 5.0, contained 0.1 M sodium acetate, 7.5 mM L-( +) tartaric acid, 0.2 mM 
naphthol AS-MX and 1.5 mM fast red violet LB salt (Sigma Aldrich). Cells were stained at 37 °C for 30 min. 
Transmitted light microscopy at 10× optical magnification was used to record images from 10 different areas of 
each disc. NIS-elements advanced research software (Nikon) was used to identify multinucleated TRAP positive 
osteoclasts to derive an average number of cells per  mm2.
Following osteoclast cell counts, cells were removed from the dentine discs using cotton buds and 0.25 M 
ammonium hydroxide. The dentine discs were then stained by immersion in 1% toluidine blue dissolved in 
0.1 M sodium tetraborate for 3 min. Discs were then rinsed in water to remove excess staining. Transmitted 
light microscopy was used at 10 × optical magnification to take 10 images from different areas of each disc. Using 
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NIS-elements advanced research software (Nikon), average values were obtained for number of pits/mm2 and 
average pit size (µm) for each disc.
in vivo assessment of osteoblast and osteoclast mitochondrial respiratory chain protein 
expression. Quadruple immunofluorescence was performed to quantify levels of mitochondrial proteins 
in osteoblasts and osteoclasts as previously  described44. Comparisons were made between wild type mice aged 
4 and 11 months, and PolgAmut/mut mice aged 11 months. Data from 4-month-old wild type animals were used 
as the reference control. An antibody to cathepsin K was used to detect osteoclasts, and respiratory chain com-
plex subunits within were detected using mouse monoclonal primary antibodies against NADH dehydrogenase 
[ubiquinone] I beta subcomplex subunit 8 (NDUFB8) and cytochrome c oxidase (COX) subunit 1 (COXI). 
These were applied in combination with a monoclonal antibody against the outer mitochondrial membrane 
protein porin (VDAC1). Porin is a nuclear-encoded, voltage gated ion channel present in abundance in the mito-
chondrial membrane, and its presence serves as a marker for mitochondrial  mass57. NDUFB8 is a nuclear-DNA 
encoded subunit of Complex  I58 and COX-I is a mtDNA-encoded subunit of Complex  IV59.
Imaris image analysis software (Bitplane, v.8.4) was used to detect osteoclasts (546 nm) and areas within 
these that were positive for the mitochondrial mass marker porin (405 nm). For each of these areas of intracel-
lular mitochondrial staining, the software provided average signal intensity values for porin (405 nm), COX-I/
MTCO1 (488 nm) and Complex I/NDUFB8 (647 nm) within each cell.
Statistical analysis. Prism (GraphPad) was used for all statistical analysis of micro CT scan, histomorpho-
metry and cell culture data. Rstudio was used for analysis of osteoclast immunofluorescence data.
Results
Micro-ct scanning of femurs and lumbar spines demonstrates accelerated bone loss in Pol-
gAmut/mut mice. Bone volume/tissue volume (BV/TV) of extracted femurs was evaluated using micro-CT 
scanning (Fig. 1) and unpaired 2-tailed t tests for comparisons. The femoral BV/TV decreased at an accelerated 
rate in PolgAmut/mut mice compared to age and sex matched wild type controls with a significantly reduced trabec-
ular BV/TV in both female and male PolgAmut/mut mice by the ages of 7 and 11 months respectively (p = 0.003 and 
< 0.0001). The same comparisons (Supplemental Data S1) also show reduced levels of trabecular bone thickness, 
increased trabecular separation and reduced trabecular number in 11 month old PolgAmut/mut males (p = 0.0009, 
0.007 and 0.025 respectively) and in 7 month old PolgAmut/mut females (p = 0.251, < 0.0001 and 0.004 respectively). 
A decrease in trabecular BV/TV of male and female wild type mice, with increasing age is also observed. Female 
wild type mice demonstrate significantly reduced BV/TV compared to age matched wild type males at all 3 ages 
studied (p < 0.001).
Assessment of cortical bone thickness (Fig. 1 and Supplemental Data S1) showed that it continued to increase 
in wild type mice between the ages of 4 and 7 months in females, in keeping with previous  work40. How-
ever, significantly reduced cortical thickness was seen in PolgAmut/mut female mice at 7 months (p = 0.032), and 
at 11 months of age (p = 0.005). Male PolgAmut/mut mice exhibited significantly reduced cortical thickness at 
11 months of age (p = 0.0008).
Trabecular bone from extracted lumbar vertebrae (L5) was also assessed (Fig. 1 and Supplemental Data 
S2). Compared with wild-type controls, a significantly reduced BV/TV was observed in PolgAmut/mut males at 
4, 7 and 11 months of age (p = 0.035, 0.033, and < 0.0001 respectively), and in PolgAmut/mut female mice at 7 and 
11 months of age (p = 0.0004 and 0.007 respectively). This corresponded with reduced trabecular thickness at 7 
and 11 months in PolgAmut/mut males (p = 0.016 and 0.002 respectively) and PolgAmut/mut females (p = 0.040 and 
0.0001 respectively). In PolgAmut/mut males, increased trabecular separation was observed at 4, 7 and 11 months 
(p = 0.005, 0.027 and 0.003 respectively), with reduced trabecular number at 4 and 11 months (p = 0.033 and 
< 0.0001 respectively). PolgAmut/mut females exhibited increased trabecular separation and reduced trabecular 
number at 7 months (p = 0.013 and < 0.0001 respectively). Again, exercise was not associated with any difference 
in trabecular bone mass observed in PolgAmut/mut male mice at 11 months.
Comparison of exercised and non-exercised male PolgAmut/mut mice aged 11 months demonstrated that exer-
cise did not affect any of the studied parameters on micro CT scan of whole femurs (trabecular BV/TV, trabecular 
thickness, trabecular separation, trabecular number) or lumbar vertebrae (trabecular BV/TV, trabecular thick-
ness, trabecular separation, trabecular number). However, a reduction in cortical thickness was observed in 
exercised PolgAmut/mut mice (p = 0.038).
Histomorphometry shows reduced BV/tV, reduced bone formation rate, reduced osteoblast 
population density, and increased osteoclast population density in PolgAmut/mut mice. The 
extracted tibiae of age matched wild type and PolgAmut/mut mice were compared (unpaired 2 tailed t-tests). BV/
TV and mineralisation (osteoid surface/bone surface) were found to be significantly lower in PolgAmut/mut mice 
(p = 0.017 and 0.010 respectively) compared to age matched wild type mice.
Analysis of mineralisation fronts following staged injection of alizarin complexone and calcein demonstrated 
significantly reduced bone formation rates (p = 0.0088) in PolgAmut/mut mice. The in vivo population densities of 
osteoblasts in PolgAmut/mut mice was found to be significantly lower (p = 0.005), but conversely, that of osteoclasts 
was significantly (p = 0.017) higher (Fig. 2).
functional capacity of osteogenic cells to produce mineralised matrix in vitro is reduced in 
PolgAmut/mut cells. Mineralisation assays were performed using bulk unfractionated skeletal mesenchymal 
cells. The average surface area of mineralised matrix formed and corresponding surface area occupied by cells 
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expressing ALP were recorded (Supplemental Data S3) for each cell line. Wild type osteogenic cells consistently 
produced mineralised matrix in abundance as demonstrated by increased alizarin red staining. The ratio of min-
eralised matrix surface area to surface area occupied by ALP positive cells (Fig. 3) fell with increasing age in the 
wild type mice, with significant reduction in mineralised matrix formation by 7 and 11 months in comparison to 
that at 4 months in both sexes (one way ANOVA, Bonferroni p < 0.001). Osteogenic cells differentiated from cells 
Figure 1.  Micro-CT scan of femurs and lumbar spines demonstrate accelerated bone loss in PolgAmut/mut 
mice. An exercise intervention was not associated with a change in trabecular bone mass. A significant decline 
in femoral trabecular BV/TV can be seen by 7 months of age in female (A) PolgAmut/mut mice (p = 0.003) and 
by 11 months of age in male (B) PolgAmut/mut mice (p < 0.0001) when compared to age matched wild type 
controls (unpaired 2 tailed t-test). A similar pattern of bone loss was seen in the lumbar spine with significant 
reductions in trabecular BV/TV in female PolgAmut/mut mice at 7 and 11 months (C), and in male PolgAmut/mut 
mice at 4, 7 and 11 months (D), compared to age and sex matched wild type controls. Cortical thickness was 
also significantly reduced in female PolgAmut/mut mice at 7 and 11 months (E), and in male PolgAmut/mut mice at 
11 months (F), compared to wild type controls. Exercise had no significant effects (ns) on bone mass observed 
in 11 month old PolgAmut/mut males in terms of trabecular BV/TV (B, D). A gradual decline in BV/TV levels is 
observed in wild type mice as a feature of advancing age, with females showing a significantly reduced femoral 
trabecular BV/TV in comparison to age matched males at 4, 7 and 11 months of age (p = 0.0004, p = 0.0015, 
p < 0.0001 respectively (unpaired 2 tailed t-test)).
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harvested from male and female PolgAmut/mut mice aged 4, 7 and 11 months all produced significantly less min-
eralised matrix in comparison to age and sex matched wild type controls (p < 0.0001, unpaired 2 tailed t-test).
The exercise intervention made no significant difference to the capacity of osteogenic cells extracted from 
PolgAmut/mut mice aged 11 months to produce mineralised matrix in vitro. No significant difference was observed 
in propensity for cell differentiation to ALP expressing osteogenic cells in this cell line either.
Propensity of osteogenic cell differentiation to cells expressing ALP is unaffected in MSCs har-
vested from PolgAmut/mut mice. The population density of ALP positive cells derived from bulk unfrac-
tionated skeletal mesenchymal cell harvest was examined by correlating the ratio of number of ALP positive 
cells to the number of all cell types (identified by nuclear Hoescht staining) for each mouse of origin (Fig. 4). 
One-way ANOVA and Bonferroni post-test comparisons showed no significant difference between wild type 
and PolgAmut/mut cell lines in their propensity for osteogenic cell differentiation in male and female cell lines at 
all 3 ages. Significant variation in final population density of ALP positive cells is evident in age/sex matched 
Figure 2.  Hitomorphometric analysis shows reduced bone density, reduced bone formation rate, reduced 
osteoblast population density, and increased osteoclast population density in PolgAmut/mut mice. BV/TV (A) 
and mineralisation (OS/BS%) (B) is significantly lower in PolgAmut/mut mice compared to age matched wild type 
(WT) mice (p = 0.017 and 0.010 respectively). von Kossa staining of WT and PolgAmut/mut mice (C). BFR were 
significantly lower (p = 0.0088) in PolgAmut/mut mice compared to age matched WT (D). Immunofluorescent 
imaging of tissue sections from tibiae of WT and PolgAmut/mut demonstrate the typical difference in BFR 
observed between the two genotypes (E). Significantly reduced osteoblast population densities (p = 0.005) 
in PolgAmut/mut mice compared to age matched WT mice are observed (F). Typical appearances of WT and 
PolgAmut/mut tibiae sections stained with toluidine blue, with red arrows demarcating bone-lining osteoblasts 
(G). There are significantly increased population densities of osteoclasts in PolgAmut/mut mice compared to 
age matched WT, with higher osteoclast numbers (H) and osteoclast surface area relative to bone surface 
(I) (p = 0.017 and 0.023 respectively). Typical appearance of TRAcP stained tibiae sections from WT and 
PolgAmut/mut mice (J).
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groups with no significant positive correlation (Pearson) found in any age/sex matched cell line between the 
number of ALP positive cells formed and total number of cells present as identified by Hoechst nuclear staining 
(Supplemental Data S4).
osteoclast in vitro resorption assays demonstrate increased osteoclast activity. Following 
monocyte extraction from mice aged 11 months, and osteoclast culture on dentine discs, cells were removed and 
Figure 3.  PolgAmut/mut osteogenic cells produce less mineralised matrix in vitro. Ratio of mineralised matrix 
surface area to surface area occupied by osteogenic ALP positive cells. A gradual decline in mineralised matrix 
formation is seen with increasing age in wild type cells extracted from both females (A) and males (B), with a 
significant reduction observed by 7 and 11 months in comparison to cells from mice aged 4 months (p < 0.001, 
one way ANOVA, Bonferroni). At all three ages of study, and in both sexes, mineralisation by PolgAmut/mut cells is 
vastly reduced (p < 0.0001, unpaired, 2 tail t-testing). The functional capacity of PolgAmut/mut cells from 11-month 
old exercised male mice to produce mineralised matrix was not significantly (ns) different to that observed in 
cells derived from non-exercised 11 month old male PolgAmut/mut mice (p = 1). Typical appearances of wild type 
cell lines (C, D) and PolgAmut/mut cell lines (E, F) taken from mice aged 11 months are shown.
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resorption pits were studied. Unpaired 2 tailed t-tests were performed for all comparisons. The resorption pits 
formed by wild type osteoclasts were larger than those formed by PolgAmut/mut osteoclasts with average sizes of 
534 µm and 333 µm respectively (p = 0.0008).
The ratio of resorption pits to osteoclasts was analysed (Fig. 5). The ratio of pits to osteoclasts was significantly 
higher following PolgAmut/mut osteoclast culture, with 9.3 pits observed per osteoclast compared to only 3.2 pits 
per osteoclast following wild type osteoclast culture (p < 0.0001). The total resorption area per osteoclast was also 
significantly higher following PolgAmut/mut osteoclast culture at 2951 µm per osteoclast compared to 1737 µm of 
resorption on average by wild type osteoclasts (p = 0.0134).
High levels of variability are observed between dentine discs within individual cell lines and also between cell 
lines of the same genotype for number of pits and also in the resorption area recorded per osteoclast, particularly 
within the PolgAmut/mut group.
Figure 4.  Population density of ALP positive, osteogenic cells, derived from bulk unfractionated mesenchymal 
cell harvests. The ratio of ALP positive cells to total cell number was recorded as a measure of osteogenic cell 
population density, for female (A) and male (B) mice. Significant variation in the population density of ALP 
positive cells occurred in all groups. There was no significant difference (one-way ANOVA/Bonferroni) between 
wild type cells and PolgAmut/mut cells (regardless of sex or age of mouse of origin), in their propensity to produce 
osteogenic cells, suggesting that reduced mineralised matrix formation in vitro by PolgAmut/mut cell lines is not 
accounted for by reduced population density of osteogenic cells.
Figure 5.  Osteoclast resorption assays using cells extracted from wild type and PolgAmut/mut mice aged 
11 months. Comparisons between wild type (WT) and PolgAmut/mut cell lines. Average size of resorption pits 
formed by WT osteoclasts (A) was larger than those formed by PolgAmut/mut osteoclasts (p = 0.0008). The ratio 
of resorption pits to osteoclasts was higher (B) in PolgAmut/mut cells (p < 0.0001). The ratio of resorbed dentine to 
osteoclast number (C) was also higher in PolgAmut/mut cells (p = 0.0134). Examples of appearances of osteoclasts 
on dentine (D) and visualisation of resorption pits (E).
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Respiratory chain protein expression declines in osteoblasts and osteoclasts of aging mice, 
and at an accelerated rate in PolgAmut/mut mice. We have previously shown that a significant reduc-
tion in mitochondrial protein expression within osteoblasts occurs between the age of 4 and 11 months in wild 
type mice, with the levels of the respiratory chain proteins COX-I and NDUFB8 levels declining by 1.8 SD and 
1.9 SD respectively. In PolgAmut/mut mice aged 11 months, COX-I and NDUFB8 levels are 13.4SD and 8.2 SD 
lower respectively in osteoblasts when compared to osteoblasts within wild type mice aged 4 months44. Here we 
investigated mitochondrial protein expression within osteoclasts using the same methodology. Mitochondria 
within osteoclasts of wild type mice aged 4 months (n = 7) and 11 months (n = 7) were compared to 11 month 
PolgAmut/mut mice (n = 7). The relationship between mitochondrial mass (porin), COX-I and NDUFB8 protein 
abundance in 4 month-old control mice is generally linear albeit with some variation, and there is evidence that 
some osteoclasts express low levels of COX-I and NDUFB8 even in these young control mice. In wild type mice 
aged 11 months, visibly higher variation was apparent with some loss of the linear relationship. This was even 
more apparent in 11 month PolgAmut/mut animals with many cells observed displaying low COX-I and NDUFB8 
protein abundance (Fig. 6). In osteoclasts from wild-type mice, mean COX-I and NDUFB8 levels decline with 
age by 0.76 SD and 0.36 SD respectively, from 4 to 11 months. In 11 month PolgAmut/mut osteoclasts, COX-I and 
NDUFB8 protein expression in was 1.22 SD and 0.77 SD lower than in osteoclasts from wild type mice aged 
4 months. When age-matched wild type and PolgAmut/mut mice were compared (both 11 months old), COX-I 
and NDUFB8 levels in the latter were found to be 0.46 SD and 0.36SD lower respectively in PolgAmut/mut osteo-
clasts. Numerical data for individual mice is shown in Supplemental Data S5. On average, 15.2% and 6.4% of 
PolgAmut/mut osteoclasts showed some degree of COX-I and NDUFB8 deficiency respectively (intermediate posi-
tive, intermediate negative or negative classification), compared to 10.8% and 3.6% of osteoclasts from wild type 
mice aged 11 months. Corresponding individual graphs for all mice, depicting NDUFB8:porin and COX-I:porin 
ratios following Z-score analysis, which clearly show deficiency type and severity are provided in Supplemental 
Data S6. Figure 7 shows representative examples of these graphs for 4 month old wild type, 11 month old wild 
type and 11 month old PolgAmut/mut mice.
Discussion
With age, somatic mtDNA mutations accumulate in mitotic and post mitotic tissue, and somatic stem cell 
 precursors60. We have demonstrated that  osteoblasts44 osteoclast accumulate mitochondrial defects occur within 
ageing wild type mice and at an accelerated rate in PolgAmut/mut mice, and that these findings correspond to 
increased bone loss, reduced bone formation rate, reduced osteoblast population density, and increased osteo-
clast population density in vivo. A corresponding decline in the capacity of osteogenic cells to form mineralised 
matrix, and increased osteoclast resorption activity in vitro were also demonstrated. We found that exercise did 
not affect bone mass or rescue the impaired function of extracted osteoblasts.
Figure 6.  NDUFB8:Porin and COX-I:Porin in mouse osteoclasts. Log transformed background corrected 
signal intensities of porin, COX-I and NDUFB8 within individual osteoclasts were recorded. A linear 
association of NDUFB8 and COX-I to porin is present which is strongest in wild type mice aged 4 months. With 
increasing age in wild type mice, increasing variation in COX-I and NDUFB8 signal occurs with some loss of 
the linear relationship. This change is more marked in PolgAmut/mut mice aged 11 months in which many cells 
exhibited low COX-I and NDUFB8 protein expression (different colours within each age group signify different 
cell lines).
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Mutations and consequent dysfunction in other tissues in the PolgAmut/mut mouse model are cumulative with 
 age37, hence our assessment of bone phenotype at different ages. With micro CT scanning, we found a significant 
reduction in lumbar vertebral BV/TV in male PolgAmut/mut mice as young as 4 months and by 7 months in female 
PolgAmut/mut mice. With advancing age, accelerated lumbar spine bone loss continues with significant deficits 
shown in male PolgAmut/mut mice at 7 and 11 months, and female PolgAmut/mut mice at 11 months, compared to 
age and sex matched wild type mice. Femoral trabecular bone shows a similar pattern of accelerated loss in 
PolgAmut/mut mice with significant reductions in BV/TV seen in females by 7 months, and males by 11 months. It 
is not clear why the rate of femoral trabecular bone loss appears to slow in female PolgAmut/mut mice after the age 
of 7 months, with no significant difference in BV/TV observed by the age of 11 months when compared with 
age matched wild type mice, although significant deficits in lumbar spine BV/TV were still apparent at this age. 
At each of the time points studied (4, 7 and 11 months), micro CT scan showed that BV/TV in male mice was 
higher than that of females, regardless of genotype, illustrating the significant role that sex hormone composition 
plays in bone biology. Our data for wild type mouse femoral and vertebral BV/TV is in keeping with previous 
 work61 and the patterns of bone loss in PolgAmut/mut mice mirrors that seen in wild type mice, further validating 
the usefulness of this model. In keeping with these findings, in vivo assessment showed significantly reduced 
BV/TV in PolgAmut/mut mice compared to age and sex matched wild type mice.
Analysis of bone formation rates in vivo showed significantly reduced levels of osteogenesis at the mineralisa-
tion front in PolgAmut/mut mice compared to age and sex matched wild type mice. This correlated with a signifi-
cantly reduced population density of osteoblasts observed in this mouse model. Mitochondrial dysfunction in 
other tissues and organs may contribute to the osteoporotic phenotype of PolgAmut/mut mice, hence our desire to 
study the function of osteogenic cells in vitro, with the effects of whole body physiology eradicated. In keeping 
Figure 7.  Representative graphs of Z-scored NDUFB8:Porin and COX-I:Porin for wild type and PolgAmut/mut 
mice osteoclasts. Z-scores are derived for porin, NDUFB8 and COX-I from the mean and standard deviations 
of NDUFB8:porin and COX-I:porin relationships, in wild type controls aged 4 months. The Z scores for 
NDUFB8:porin and COX-I:porin are plotted against each other for each mouse, with each dot representing 
an individual osteoclast and it’s colour signifying the porin level (dark purple, very low; light purple, low; 
grey, normal; orange, high; red, very high). The typical appearances for a wild type mouse aged 4 months (A), 
wild type mouse aged 11 months (H), and PolgAmut/mut mice aged 11 months (T and U) are shown (lettering 
corresponds to that in Supplemental Data S5 and S6). Most data points are no more than 3SD from the mean 
in the control group (wild type mice aged 4 months). However, in wild type mice aged 11 months reduced 
NDUFB8 and COX-I protein expression is observed and this deficit occurs to a greater degree in PolgAmut/mut 
mice of the same age. The percentage of osteoclasts which are positive, intermediate positive, intermediate 
negative or negative for COX-I and NDUFB8 for each mouse are also shown, in the smaller panels to the right 
of each graph.
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with the reduced bone formation rates observed in vivo, PolgAmut/mut ALP positive osteogenic cells produced 
significantly less mineralised matrix in vitro than age and sex matched wild type cells. Mineralised matrix 
was produced in abundance when using osteogenic cells derived from wild type bulk unfractionated skeletal 
mesenchymal cells in keeping with work using human and mouse  MSCs62,63. However, with increasing age of 
wild type mice, which accumulate mitochondrial DNA mutations at a much slower rate than their PolgAmut/mut 
counterparts, declining levels of mineralised matrix were produced, a finding which correlates with increasing 
in vivo bone loss and reducing osteoblast mitochondrial respiratory protein expression with advancing  age44. 
A limitation in our study is the use of bulk unfractionated mesenchymal cells, rather than the use of purified 
osteogenic mesenchymal stem cells harvested using a method such as flow cytometry, and it would be useful to 
validate our findings using a method such as this.
MtDNA mutations are known to accumulate in stem cell populations with  age64. The effect of these mtDNA 
mutations has been shown to vary depending on the cell line  affected65,66. There have been no previous reports 
of the effects on cells of the MSC lineage. Although the population densities of ALP producing cells seen in our 
in vitro analysis showed no discernible difference between PolgAmut/mut and wild type cell lines, our in vivo analysis 
showed significant reduction in numbers of mature bone lining osteoblasts. Clearly mitochondrial dysfunction 
is associated with abnormal differentiation of MSCs through an osteogenic lineage, with reduced population 
densities of mature bone lining osteoblasts occurring and impaired osteogenic function, as demonstrated by 
reduced in vivo bone formation rates. The capacity of osteogenic cells to produce mineralised matrix in vitro is 
also significantly impaired. During osteogenic differentiation of human MSCs, increasing levels of intracellular 
ATP content, mitochondrial DNA (mtDNA) copy number and protein subunits of respiratory enzymes occur, 
which correlates with increased oxidative phosphorylation during early  differentiation67,68. Wnt signalling is vital 
for osteoblast differentiation, proliferation and subsequent mineralisation and it also appears to be intrinsically 
linked to mitochondrial  biogenesis69,70. This relationship appears to be mutual as when mitochondrial biogen-
esis is enhanced following upregulation of TFAM activity in mouse mesenchymal cells in vitro, Wnt induced 
β-catenin expression and osteogenesis is significantly  enhanced69.
Non-weight bearing states and weightlessness in space are known to cause bone loss in humans and animal 
 models71,72. We found no significant difference in the weight of wild type and PolgAmut/mut mice aged 4 and 
7 months to account for differences in bone loss (data not shown), and Trifunovic et. al. did not find a significant 
difference in body weight until the age of 39 weeks (37). However, we acknowledge that significantly reduced 
body weight in PolgAmut/mut mice by the age of 11 months may contribute to accelerated bone loss at this stage. 
Exercise has been shown to enhance respiratory chain activity in human muscle 42 and a similar exercise regime 
to ours has been shown to be protective against the ageing phenotype of PolgAmut/mut mice when applied from the 
ages of 3 to 8 months, although the effects of exercise on bone loss was not  evaluated40. We found that exercise 
did not affect bone mass in male PolgAmut/mut mice and that osteogenic cells extracted from these mice exhibited 
the same reduced functional capacity as cells from non-exercised PolgAmut/mut mice of the same age. Subtle vari-
ations between the exercise protocols used in ours and previous work may have contributed to the lack of effect 
observed. Recent work studying the effects of exercise on bone mass in wild type C57BL/6 mice shows that the 
intensity of exercise is critical with no significant increase in bone mass occurring when intensity is too low or 
too  high73. The authors suggest that a minimum threshold of exercise must be reached to achieve a positive effect 
on bone density accrual and hypothesise that increased free radical production with excessive exercise, impairs 
bone mass accumulation.
Our analysis of osteoclast mitochondrial respiratory chain protein expression within osteoclasts showed that 
both COX-I and NDUFB8 protein expression levels decline with advancing age in wild type mouse osteoclasts 
and at an accelerated rate in PolgAmut/mut mice. However, the decline was much more modest than that observed 
in osteoblasts 44. These results suggest that cells of the osteoclast lineage are less vulnerable to mitochondrial 
dysfunction with advancing age and in the PolgAmut/mut mouse model, than cells of the osteoblast lineage. Alter-
natively, osteoclasts may be more dependent on preserved mitochondrial function, perhaps meaning that only 
those with normal respiratory chain function develop or survive in vivo. We found that the respiratory chain 
deficiency observed in osteoclasts is associated with an increased osteoclast population density in vivo in Pol-
gAmut/mut mice. Geurts et al. also noted increased osteoclast numbers in vivo in this mouse  model74. Increased 
mitochondrial biogenesis and activity has been shown to occur during osteoclast differentiation, suggesting 
some degree of normal mitochondrial function is important to the  process75–77. It is likely that a threshold of 
acceptable mitochondrial function exists, above which the cell can continue to function. Stromal and osteoblast 
expression of RANKL and M-CSF has been shown to increase with advancing age in mice, and when these cells 
are used in vitro to invoke osteoclastogenesis in osteoclast precursors, the effects are enhanced when using donor 
osteoblasts and stromal cells from older  animals78. It is not clear whether upregulation of these factors is related 
to mitochondrial dysfunction, but a potential increase of their expression in PolgAmut/mut mice, may explain the 
findings in our in vivo work. Similar findings are apparent in human whole bone and cultured marrow cells, 
with increasing expression of RANKL and reducing expression of OPG with advancing age. Overexpression of 
RANKL or under expression of OPG has been shown to lead to severe  osteopenia79,80. The osteoclast progenitor 
pool, the expression of RANK (receptor to RANKL) and c-fms (receptor to M-CSF) have also been shown to 
increase with  age78,81,82. Again, it not clear whether these changes are intrinsically linked to changes in cellular 
mitochondrial function.
Osteoclast-specific knock out of TFAM, which results in a reduction in mitochondrial gene expression and 
consequent mitochondrial dysfunction, has been shown to be associated with enhanced osteoclast resorption 
activity despite significantly reduced ATP content and accelerated apoptosis 38. In keeping with these findings, 
our in vitro work also demonstrates enhanced osteoclast activity, with significantly increased resorption by 
PolgAmut/mut osteoclasts with an increased ratio of pits per osteoclast, and increased ratio of dentine resorbed per 
osteoclast. Variability observed between dentine discs within individual cell lines and also between cell lines 
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of the same genotype for number of pits and also in the resorption area recorded per osteoclast, is likely to be 
accounted for by the cell culturing process, related to the harvest of variable numbers of monocytic cells when 
removing non-adherent cells from flasks.
Whilst osteoclast differentiation and resorption is clearly affected, the primary defect in bone homeostasis 
in the PolgAmut/mut mouse model, appears to be one of reduced bone formation.
We believe that this is the first work to show that mitochondrial dysfunction, a universal feature of human 
ageing, severely impairs osteogenesis and is associated with accelerated bone loss. Although mitochondrial 
dysfunction in bone cells appears to have a direct effect on bone phenotype, the secondary effects on bone of 
mitochondrial dysfunction within other tissues, remains unclear. Further understanding of the potential role 
of mitochondrial dysfunction in failing bone biology is crucial. Although PolgAmut/mut mice accumulate mtDNA 
mutations at 3–5 times of wild type mice, the resultant mitochondrial dysfunction is sufficient by 4 months of 
age to cause marked dysfunction with associated bone loss. Although humans accumulate mtDNA mutations at 
a slower rate than this, the lifespan of humans is such that the cumulative effects of these on bone homeostasis 
is a potentially significant factor in the development of osteoporosis and further investigation using human tis-
sues and cell lines is warranted.
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